The real risks of psychedelics, explained by Johns Hopkins professor Dr. Matthew Johnson.

A pattern emerges when you compare the harmfulness of different types of psychoactive drugs: alcohol and hard drugs like heroin and crack cocaine rank as the most harmful, while psychedelic substances like psilocybin and LSD score as the least harmful.

It’s perhaps not too surprising. After all, psychedelic substances are generally non-toxic and medically safe to consume. The drugs do not come with the same kind of overdose risks that substances like alcohol and heroin do.

Still, psychedelics can have profound effects on the psyche. Bad trips are a real phenomenon. But bad trips are sometimes the result of an interplay between the drugs and the user’s environment. As explained by Dr. Matthew W. Johnson, a professor of psychiatry and behavioral sciences at Johns Hopkins, the conditions under which someone experiences psychedelics can significantly influence the trip — for the worse or the better.

-------------------------------------------------------------------------------------------------------------------------------------------------------------

Go Deeper with Big Think:

►Become a Big Think Member

Get exclusive access to full interviews, early access to new releases, Big Think merch and more

►Get Big Think+ for Business

Guide, inspire and accelerate leaders at all levels of your company with the biggest minds in business

Listen To This Next:

Adam Grant's #1 phrase to unlock potential

The science of super longevity

Beat anxiety with the most addictive experience on Earth

------------------------------------

About Matthew Johnson:

Matthew W. Johnson, Ph.D., is The Susan Hill Ward Endowed Professor of Psychedelics and Consciousness Research at Johns Hopkins. Working with psychedelics since 2004, he is one of the world’s most widely published experts on psychedelics. He has published research on psychedelics and mystical experience, personality change, tobacco smoking cessation, cancer distress treatment, and depression treatment. In 2021 he received as principal investigator the first grant in 50 years from the US government for a treatment study with a classic psychedelic, specifically psilocybin in treatment of tobacco addiction. He is also known for his expertise in behavioral economics, addiction, sexual risk behavior, and research with a wide variety of drug classes. He’s been Interviewed by Anderson Cooper on 60 Minutes, the New York Times, the Washington Post, the Wall Street Journal, CNN, NPR, Fox News, Fox Business News, BBC and in Michael Pollan’s book How to Change Your Mind....

--------------------------

Discover Big Think | Smarter Faster™

Your top destination for expert-driven, educational content. Featuring thousands of episodes and insights from renowned figures like Bill Clinton to Bill Nye, Big Think accelerates your learning by delving into the pivotal concepts and essential skills shaping knowledge in the 21st century...

Unlock Knowledge, Faster

With Insights from the World's Leading Minds

Remember to Follow the Podcast and Enable Notifications

If you found this episode valuable, Share It

Leave a 5-Star Review!

Learn more about your ad choices. Visit megaphone.fm/adchoices